Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

U.S. patent office rules against Amgen Humira challenge
Yahoo/Reuters
Thu, 01/14/16 - 08:49 pm
Tags:
patents, Amgen, Humira, generics, AbbVie
Roche and AbbVie line up for quick approval for cancer drug venetoclax
Fierce Biotech
Tue, 01/12/16 - 09:19 pm
Tags:
AbbVie, Roche, venetoclax, chronic lymphocytic leukemia
Biosimilars Are Coming After Big Pharma's Bottom Line
Fortune
Tue, 01/12/16 - 02:37 pm
Tags:
Big Pharma, biosimilars, Roche, AbbVie, MabThera, Herceptin, Avastin, Humira, Janssen, Remicade
AbbVie Announces the Launch of Robust Phase 3 Clinical Trial Program Evaluating ABT-494, an Investigational Selective JAK1 Inhibitor, for the Treatment of Rheumatoid Arthritis
Yahoo
Fri, 01/8/16 - 09:49 am
Tags:
AbbVie, rheumatoid arthritis, JAK inhibitors, ABT-494
Why AbbVie Inc Spent $21 Billion to Buy Pharmacyclics
Motley Fool
Wed, 01/6/16 - 10:44 am
Tags:
AbbVie, Pharmacyclics, M&A
Eli Lilly, Pfizer, J&J, AbbVie Join $48M Bet On NYC Cancer Drug Startup
Forbes
Wed, 01/6/16 - 10:26 am
Tags:
Eli Lilly, Pfizer, JNJ, AbbVie, Petra Pharma, cancer
Gilead Faces Troubled HCV Scripts as AbbVie Scripts Go Up
Bidness, ETC
Wed, 12/30/15 - 07:07 pm
Tags:
Gilead Sciences, AbbVie, hepatitis C, Sovaldi, Harvoni, Viekira Pak
Is AbbVie's Growth Story Falling to Pieces?
Motley Fool
Sat, 12/26/15 - 12:01 pm
Tags:
AbbVie, Humira, AstraZeneca, Acerta Pharma, acalabrutinib
Did AbbVie Blow $21 Billion Buying Pharmacyclics?
Motley Fool
Tue, 12/22/15 - 10:02 pm
Tags:
AbbVie, Pharmacyclics, M&A
Is Merck & Co. About to Derail Gilead Sciences?
Motley Fool
Tue, 12/22/15 - 09:59 pm
Tags:
Merck, Gilead Sciences, grazoprevir/elbasvir, Viekira Pak, AbbVie
AstraZeneca's Acerta deal could put the hurt on AbbVie's Imbruvica
Fierce Pharma Marketing
Tue, 12/22/15 - 10:40 am
Tags:
AstraZeneca, Acerta, AbbVie, M&A, Imbruvica
Are Gilead Sciences, AstraZeneca Deals a Threat to AbbVie?
Bidness, ETC
Sun, 12/20/15 - 04:45 pm
Tags:
Gilead Sciences, AstraZeneca, AbbVie, filgotinib, Acerta Pharma, Galapagos
AstraZeneca, Gilead Drug License Deals Could Pinch AbbVie Growth
TheStreet.com
Thu, 12/17/15 - 09:40 am
Tags:
AstraZeneca, Gilead Sciences, AbbVie, Acerta Pharma, Galapagos
Major Pharma Group Outlook In 2016: Fundamentals To Outweigh Political Headwinds
Yahoo/Benzinga
Sun, 12/13/15 - 11:13 am
Tags:
Bristol-Myers Squibb, AbbVie, Merck, Eli Lilly, Zoetis
ASH scorecard: AbbVie rides high, GBT slips and Celgene settles in
Fierce Biotech
Wed, 12/9/15 - 11:45 am
Tags:
AbbVie, Celgene, Roche, Global Blood Therapeutics
Here’s How AbbVie, JNJ May Turn Imbruvica into a $12 Billion Drug
Bidness, ETC
Mon, 12/7/15 - 10:37 am
Tags:
AbbVie, JNJ, Imbruvica, chronic lymphocytic leukemia
AbbVie Announces FDA Acceptance of New Drug Application for a Once-Daily Formulation of VIEKIRA PAK to Treat Genotype 1 Chronic Hepatitis C Virus Infection
Yahoo
Wed, 12/2/15 - 09:28 am
Tags:
AbbVie, hepatitis C, Viekira Pak
Can Bristol-Myers Squibb And AbbVie's Empliciti Become a Top Seller?
Motley Fool
Tue, 12/1/15 - 01:18 pm
Tags:
AbbVie, Bristol-Myers Squibb, Empliciti, Multiple Myeloma
Why AbbVie was not Impacted by Amgen Humira Biosimilar Submission
Bidness, ETC
Mon, 11/30/15 - 09:27 am
Tags:
AbbVie, Humira, Amgen, biosimilars, ABP 501
Amgen applies to FDA for competitor drug to AbbVie's Humira
Marketwatch
Wed, 11/25/15 - 06:43 pm
Tags:
Amgen, FDA, AbbVie, Humira, biosimilars, psoriasis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.